LifeMD, Inc. (LFMDP) vs Minerva Neurosciences, Inc. (NERV)
A side-by-side comparison of LifeMD, Inc. and Minerva Neurosciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
LFMDP
LifeMD, Inc.
$21.70HealthcareDelayed quote: Oct 6, 2026, 11:23 AM EDT
NERV
Minerva Neurosciences, Inc.
$3.37HealthcareDelayed quote: Oct 6, 2026, 11:31 AM EDT
Total return — LFMDP vs NERV
growth of $100 · dividends reinvested · last 5yLFMDP +67.0% (+10.8%/yr)NERV -72.5% (-22.8%/yr)LFMDP compounded faster over this window
Log scale — wide-divergence pair
LFMDP NERV
LFMDP vs NERV: by the numbers
- •NERV is the larger company ($157M vs $148M market cap).
- •Both run net losses; NERV's is the smaller (0.00% vs -10.40% net margin).
- •LFMDP pays a dividend (9.71% yield), while NERV has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | LFMDP | NERV |
|---|---|---|
| P/S ratio | 0.72 | N/A |
| P/B ratio | 18.57 | N/A |
Profitability
| Metric | LFMDP | NERV |
|---|---|---|
| Gross margin | 85.91% | 0.00% |
| Operating margin | -9.35% | 0.00% |
| Net margin | -10.40% | 0.00% |
| ROE | -266.86% | N/A |
| ROIC | -143.97% | -38.56% |
Dividends
| Metric | LFMDP | NERV |
|---|---|---|
| Dividend yield | 9.71% | N/A |
Growth (annualized)
| Metric | LFMDP | NERV |
|---|---|---|
| Revenue CAGR (5Y) | 26.00% | N/A |
| Total return CAGR (5Y) | 10.80% | -22.14% |
Frequently asked
- Does LFMDP or NERV pay a bigger dividend?
- LFMDP pays a dividend (9.71% yield), while NERV has no payments in the available dividend history.
- How have LFMDP and NERV total returns compared?
- Over the past 5 years, LFMDP delivered 10.80% and NERV delivered -22.14% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
LifeMD dividend yieldLifeMD ROEMinerva Neurosciences ROELifeMD operating marginMinerva Neurosciences operating marginLifeMD revenue growthMinerva Neurosciences revenue growthLifeMD free cash flowMinerva Neurosciences free cash flow
LifeMD & Minerva Neurosciences appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.